Vertex Pharmaceuticals Inc (VRTX)
397.48
-0.22
(-0.06%)
USD |
NASDAQ |
Apr 26, 16:00
395.50
-1.98
(-0.50%)
Pre-Market: 08:20
Vertex Pharmaceuticals Market Cap: 102.67B for April 26, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
April 26, 2024 | 102.67B |
April 25, 2024 | 102.73B |
April 24, 2024 | 103.52B |
April 23, 2024 | 104.59B |
April 22, 2024 | 103.30B |
April 19, 2024 | 101.85B |
April 18, 2024 | 101.64B |
April 17, 2024 | 101.54B |
April 16, 2024 | 101.82B |
April 15, 2024 | 102.64B |
April 12, 2024 | 102.43B |
April 11, 2024 | 103.38B |
April 10, 2024 | 102.70B |
April 09, 2024 | 104.48B |
April 08, 2024 | 104.41B |
April 05, 2024 | 105.05B |
April 04, 2024 | 104.36B |
April 03, 2024 | 105.60B |
April 02, 2024 | 105.76B |
April 01, 2024 | 108.61B |
March 28, 2024 | 107.98B |
March 27, 2024 | 107.80B |
March 26, 2024 | 108.09B |
March 25, 2024 | 107.46B |
March 22, 2024 | 107.37B |
Date | Value |
---|---|
March 21, 2024 | 107.38B |
March 20, 2024 | 106.45B |
March 19, 2024 | 107.25B |
March 18, 2024 | 106.26B |
March 15, 2024 | 105.31B |
March 14, 2024 | 105.59B |
March 13, 2024 | 106.73B |
March 12, 2024 | 106.54B |
March 11, 2024 | 107.06B |
March 08, 2024 | 106.83B |
March 07, 2024 | 106.05B |
March 06, 2024 | 106.38B |
March 05, 2024 | 107.31B |
March 04, 2024 | 109.53B |
March 01, 2024 | 111.79B |
February 29, 2024 | 108.68B |
February 28, 2024 | 110.29B |
February 27, 2024 | 111.31B |
February 26, 2024 | 111.97B |
February 23, 2024 | 111.10B |
February 22, 2024 | 110.24B |
February 21, 2024 | 108.39B |
February 20, 2024 | 108.65B |
February 16, 2024 | 109.06B |
February 15, 2024 | 110.11B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
42.16B
Minimum
May 13 2019
114.95B
Maximum
Jan 30 2024
68.49B
Average
66.59B
Median
Sep 10 2020
Market Cap Benchmarks
Amgen Inc | 144.69B |
Eli Lilly and Co | 697.40B |
Regeneron Pharmaceuticals Inc | 96.94B |
Alpine Immune Sciences Inc | 4.232B |
Moderna Inc | 41.34B |
Market Cap Related Metrics
PE Ratio | 28.62 |
PS Ratio | 10.49 |
PEG Ratio | 3.464 |
Price to Book Value | 5.840 |
Price to Free Cash Flow | 31.58 |
Price | 397.48 |
Earnings Yield | 3.49% |
PEGY Ratio | 3.464 |
Operating PE Ratio | 24.04 |
Normalized PE Ratio | 25.92 |